

Health Care: Drugs
Biomarin Pharmaceutical Inc. (BMRN: NASDAQ)
$64.01 -0.49 | -0.76%
05/17/13 - 04:00 PM ET
1.46M / 1.30M
Vol / Avg. Vol:
64.58 / 64.50
Open / Prev. Close:
63.30 - 65.30
Today's Range:
34.30 - 71.56
52 Wk Range:
Partner Headlines for BMRN
- Aetna Offloads Business and 4 Stocks At 52-Week Highs - Wall St. Cheat Sheet 04.02.13 | 09:04 am
- UPDATE: Piper Jaffray Raises PT on BioMarin Pharmaceutical on Positive Trial Results - Benzinga 03.20.13 | 09:03 am
- Regeneron Pharmaceuticals Inc (REGN): Today's Most Compelling Buy - NASDAQ 03.14.13 | 04:03 pm
- After-Hours Earnings Report for February 21, 2013 : AIG, HPQ, PSA, NEM, INTU, SWN, COG, JWN, SBAC, MHK, BMRN, TS - NASDAQ 02.21.13 | 07:02 pm
- Four Biotech Stocks On The Clock - Seeking Alpha 02.19.13 | 09:02 am
- BioMarin's Expanding Product Portfolio Will Lead To Gains In 2013 - Seeking Alpha 12.31.12 | 09:12 am
- Pre-Market Most Active for Nov 5, 2012 : BAC, QQQ, AAPL, BMRN, GFA, BHP, FB, UBS, RIG, NOK, ZNGA, INTC - NASDAQ 11.05.12 | 01:11 pm
- Pipeline Progress at BioMarin - Analyst Blog - Zacks 09.28.12 | 06:09 pm
- Biotechs In Motion As New Drug Pipeline Brims - Investor's Business Daily 07.27.12 | 04:07 pm
- Harley Davidson OPTIMISM and 4 Analyst Notes Making Rounds Now - Wall St. Cheat Sheet 07.02.12 | 03:07 am